Skip to main content
Tech.euFundingExplorerBeta

LiveDrop

The world’s first all-integrated instrument based on droplet microfluidics tech with the ability to detect and select biological cells such as therapeutic antibody-producing cells like monoclonal antibodies, cancer cells, rare immune cells, stem cells and fragile cells that are difficult to manipulate with classical techniques such as flow cytometers (FACS: “Fluorescence-activated cell sorter”) and multiwell plates.

Total raised
€2.3M
€2,300,000
Funding rounds
1
Investors
3
distinct backers
Active since
2022-05
latest 2022-05

Funding by year

EUR raised per year

Signals

High confidence
Raise-next likelihood11
base rate 30% for Other
  • Dormant (no round in 3+ cohort gaps)
  • Low backer re-investment

Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

1 rounds
DateStageAmountInvestors
2022-05-09Other€2.3M Innovation Fund,Noshaq the Liège,W.IN.G.View deal →

Similar companies

same sector or country